ESPE Abstracts

Introduction: Recombinant growth hormone (rhGH) treatment has been used for growth hormone (GH) induced short stature since 1985, usually with transient adverse events, while lipoatrophy involves irreversible damage to subcutaneous fatty tissue. Biopsies show mast cells and eosinophils, suggesting destructive inflammation. GH directly increases lipolysis, reduces lipoprotein lipase activity, and decreases mature adipocyte number and volume, inhibiting adipose ...

Background: Osteoporosis is very rare in childhood and main reasons are growth retardation, immobilisation, calcium and vitamin D deficiency, long term steroid therapy. There is no concensus about the treatment of children and adolescents with osteoporosis. Biphosphonates have been important in the treatment of osteoporosis.Objective and hypotheses: To evaluate the efficacy and safety of oral alendronate on bone mineral density (BMD) in children and adol...

Background: It has been reported that there is a relationship between circulating leptin and sex steroid hormones and leptin is able to stimulate estrogen secretion by increasing aromatase activity in adipose stromal cells and breast tissue. Leptin receptors have been also shown in mammary epitheleal cells and it has been suggested that leptin is involved in the control of the proliferation of both normal and malignant breast cells.Objective and hypothes...